Loading...
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...
Saved in:
| Published in: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911686/ https://ncbi.nlm.nih.gov/pubmed/27312478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0961-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|